id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2362-0006,FDA,FDA-2020-E-2362,Request for Revision of Determination of Regulatory Review Period for Purposes of Patent Extension; ENSPRYNG,Other,Petition(s),2022-09-09T04:00:00Z,2022,9,2022-09-09T04:00:00Z,,2022-09-09T13:47:27Z,,0,0,09000064852cc47d
FDA-2020-E-2362-0005,FDA,FDA-2020-E-2362,Determination of Regulatory Review Period for Purposes of Patent Extension; ENSPRYNG,Notice,Determinations,2022-07-13T04:00:00Z,2022,7,2022-07-13T04:00:00Z,2022-09-13T03:59:59Z,2023-05-24T13:13:22Z,2022-14930,0,0,09000064851c6d73
FDA-2020-E-2362-0004,FDA,FDA-2020-E-2362,Letter from FDA CDER to U S Patent and Trademark Office,Other,Letter(s),2022-06-14T04:00:00Z,2022,6,2022-06-14T04:00:00Z,,2022-06-14T17:42:37Z,,0,0,0900006485162ecf